SI0758235T1 - Polymer coated tablet comprising amoxycillin and clavulanate - Google Patents

Polymer coated tablet comprising amoxycillin and clavulanate

Info

Publication number
SI0758235T1
SI0758235T1 SI9530526T SI9530526T SI0758235T1 SI 0758235 T1 SI0758235 T1 SI 0758235T1 SI 9530526 T SI9530526 T SI 9530526T SI 9530526 T SI9530526 T SI 9530526T SI 0758235 T1 SI0758235 T1 SI 0758235T1
Authority
SI
Slovenia
Prior art keywords
amoxycillin
clavulanate
coated tablet
polymer coated
polymer
Prior art date
Application number
SI9530526T
Other languages
English (en)
Inventor
C P Conley
N P Davidson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10754044&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI0758235(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of SI0758235T1 publication Critical patent/SI0758235T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
SI9530526T 1994-04-23 1995-04-19 Polymer coated tablet comprising amoxycillin and clavulanate SI0758235T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9408117A GB9408117D0 (en) 1994-04-23 1994-04-23 Pharmaceutical formulations
PCT/EP1995/001463 WO1995028927A1 (fr) 1994-04-23 1995-04-19 Comprime enrobe d'un polymere, comprenant de l'amoxycilline et du clavulanate
EP95917937A EP0758235B1 (fr) 1994-04-23 1995-04-19 Comprime enrobe d'un polymere, comprenant de l'amoxycilline et du clavulanate

Publications (1)

Publication Number Publication Date
SI0758235T1 true SI0758235T1 (en) 2001-10-31

Family

ID=10754044

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530526T SI0758235T1 (en) 1994-04-23 1995-04-19 Polymer coated tablet comprising amoxycillin and clavulanate

Country Status (35)

Country Link
US (1) US6051255A (fr)
EP (5) EP0761218B1 (fr)
JP (1) JP3622975B2 (fr)
CN (1) CN1134258C (fr)
AP (2) AP564A (fr)
AT (6) ATE223706T1 (fr)
AU (1) AU684949B2 (fr)
BG (1) BG62842B1 (fr)
BR (1) BR9507502A (fr)
CA (1) CA2188496A1 (fr)
CZ (2) CZ11376U1 (fr)
DE (5) DE69519093T2 (fr)
DK (4) DK1093813T3 (fr)
DZ (1) DZ1876A1 (fr)
ES (4) ES2152485T3 (fr)
FI (1) FI964249A0 (fr)
GB (1) GB9408117D0 (fr)
GR (2) GR3035031T3 (fr)
HK (5) HK1050992A1 (fr)
HU (1) HU228399B1 (fr)
IL (1) IL113433A (fr)
MA (1) MA23528A1 (fr)
MY (1) MY115351A (fr)
NO (1) NO310703B1 (fr)
NZ (1) NZ285080A (fr)
OA (1) OA10377A (fr)
PL (1) PL316966A1 (fr)
PT (4) PT978276E (fr)
RO (1) RO116997B1 (fr)
RU (1) RU2152213C1 (fr)
SA (1) SA95160343B1 (fr)
SI (1) SI0758235T1 (fr)
SK (1) SK282594B6 (fr)
WO (1) WO1995028927A1 (fr)
ZA (1) ZA953236B (fr)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
ATE208618T1 (de) * 1995-09-07 2001-11-15 Smithkline Beecham Corp Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
GB9613470D0 (en) 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
GB9617780D0 (en) * 1996-08-24 1996-10-02 Smithkline Beecham Plc Method of treatment
WO1998034598A2 (fr) * 1997-02-07 1998-08-13 Gist-Brocades B.V. Formulations homogenes sous forme de granules destinees a la technologie d'aspiration des doses
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
ATE243516T1 (de) * 1997-02-14 2003-07-15 Glaxosmithkline Lab Sas Amoxicillin und clavulanat enthaltende arzneizubereitungen
EP1023065A1 (fr) * 1997-08-29 2000-08-02 Dsm N.V. Granules exempts d'excipients
WO1999022769A1 (fr) 1997-10-31 1999-05-14 Monsanto Company Enrobage de comprimes a l'aide de gomme gellane
AU3817300A (en) 1999-04-01 2000-08-01 Dsm N.V. Agglomerates by crystallisation
CN100382782C (zh) * 1999-04-13 2008-04-23 比彻姆药品(Pte)有限公司 一种释放改良型药用制剂
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US20040038948A1 (en) * 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
GB9930578D0 (en) * 1999-12-23 2000-02-16 Smithkline Beecham Plc Pharmaceutical formulations
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
AU2001279284A1 (en) * 2000-07-05 2002-01-14 Capricorn Pharma, Inc Rapid-melt semi-solid compositions, methods of making same and methods of using same
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (fr) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
WO2003066053A1 (fr) * 2002-02-07 2003-08-14 Rutgers, The State University Polymeres antibiotiques
CA2475659A1 (fr) * 2002-02-14 2003-08-21 Glaxo Group Limited Composition pharmaceutique comprenant n- ((1-n-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2h- (1, 3) oxazino (3, 2-a) indole-10-carboxamide ou un sel de celui-ci et procede associecomprenant la granulation par voie seche
GB0203528D0 (en) * 2002-02-14 2002-04-03 Glaxo Group Ltd Process and composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
KR100456833B1 (ko) * 2002-08-01 2004-11-10 주식회사 대웅 아목시실린 및 클라불라네이트를 함유하는 유핵정
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
CA2406592C (fr) * 2002-10-04 2003-09-30 Duchesnay Inc. Mode de preparation de formes posologiques pharmaceutiques contenant de multiples principes actifs
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
EP1648407A4 (fr) 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc Produit antibiotique, utilisation et formulation correspondantes
JP2006528185A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
EP1648415A4 (fr) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc Produit antibiotique, son utilisation et sa formulation
JP2007502296A (ja) * 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
AU2004264356B2 (en) * 2003-08-12 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1658034A4 (fr) * 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc Produit antibiotique, son utilisation et sa formulation
DE10341264A1 (de) * 2003-09-04 2005-03-24 Grünenthal GmbH Schmelzformulierte, multipartikuläre orale Darreichungsform
WO2005027877A1 (fr) * 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotique, son utilisation et sa formulation
CA2550983C (fr) * 2003-12-24 2013-09-17 Advancis Pharmaceutical Corporation Absorption amelioree de formes de dosage a liberation modifiee
EP1725555B1 (fr) 2004-03-08 2010-10-06 Prosidion Ltd. Hydrazides d'acide pyrrolopyridine-2-carboxylique utilises comme inhibiteurs de la glycogene phosphorylase
CA2572292A1 (fr) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Comprime pour distribution par impulsion
KR100638315B1 (ko) * 2004-07-23 2006-10-25 주식회사 대웅제약 다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
KR101318032B1 (ko) 2005-05-20 2013-10-14 다이이찌 산쿄 가부시키가이샤 필름 코팅 제제
KR100780553B1 (ko) * 2005-08-18 2007-11-29 한올제약주식회사 메트포르민 서방정 및 그의 제조방법
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
CL2008003230A1 (es) * 2007-11-01 2009-11-27 Sanofi Aventis Healthcare Pty Ltd Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
EP2477611B1 (fr) * 2009-09-18 2017-04-05 Sanofi Formulations de comprimés d'acide (z)-2-cyano-3-hydroxy-but-2-énoïque-(4'-trifluorméthylphényl)-amide à stabilité améliorée
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000687A1 (tr) 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
JP6041591B2 (ja) * 2011-09-13 2016-12-14 大日本住友製薬株式会社 イルベサルタンとアムロジピンまたはその塩を含有する安定化された医薬組成物
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1241844A (en) 1968-08-23 1971-08-04 Beecham Group Ltd Penicillins
GB1508977A (en) 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
US4098897A (en) * 1975-04-14 1978-07-04 Beecham Group Limited Anti bacterial agents
JO984B1 (en) 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
DE3266580D1 (en) * 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
CN100382782C (zh) * 1999-04-13 2008-04-23 比彻姆药品(Pte)有限公司 一种释放改良型药用制剂
EP1330236A2 (fr) * 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation

Also Published As

Publication number Publication date
DK0761218T3 (da) 2000-12-18
EP0761218A1 (fr) 1997-03-12
PT1093813E (pt) 2003-02-28
CA2188496A1 (fr) 1995-11-02
DE69528608T2 (de) 2003-06-26
HK1027024A1 (en) 2001-01-05
DK1093813T3 (da) 2003-02-17
HUT76335A (en) 1997-08-28
ATE223706T1 (de) 2002-09-15
SK282594B6 (sk) 2002-10-08
US6051255A (en) 2000-04-18
MY115351A (en) 2003-05-31
CZ11376U1 (cs) 2001-07-12
GR3036844T3 (en) 2002-01-31
FI964249A (fi) 1996-10-22
NO964488D0 (no) 1996-10-22
PT978276E (pt) 2003-01-31
GB9408117D0 (en) 1994-06-15
EP1093813A2 (fr) 2001-04-25
HK1009936A1 (en) 1999-06-11
CZ309096A3 (en) 1997-04-16
PT761218E (pt) 2001-03-30
EP1093813B1 (fr) 2002-10-16
NZ285080A (en) 1998-05-27
NO964488L (no) 1996-12-17
HU228399B1 (en) 2013-03-28
IL113433A (en) 2003-06-24
AP564A (en) 1996-11-21
DK0978276T3 (da) 2003-01-20
CN1134258C (zh) 2004-01-14
HK1050992A1 (zh) 2003-07-18
ES2161288T3 (es) 2001-12-01
DE69519093T2 (de) 2001-07-19
ZA953236B (en) 1995-12-27
DK0758235T3 (da) 2001-10-29
EP0761218B1 (fr) 2000-10-11
PL316966A1 (en) 1997-03-03
EP0978276A2 (fr) 2000-02-09
GR3035031T3 (en) 2001-03-30
HK1036404A1 (en) 2002-01-04
PT758235E (pt) 2001-10-31
DE69528204D1 (de) 2002-10-17
EP1093813A3 (fr) 2001-05-30
DE69528204T2 (de) 2003-08-07
RO116997B1 (ro) 2001-09-28
DE69528608D1 (de) 2002-11-21
HU9602922D0 (en) 1996-12-30
HK1021860A1 (en) 2000-07-07
AP9600868A0 (en) 1996-10-31
MA23528A1 (fr) 1995-12-31
AT5349U1 (de) 2002-06-25
AU684949B2 (en) 1998-01-08
SA95160343B1 (ar) 2005-05-04
OA10377A (en) 2001-11-21
DE29522153U1 (de) 2000-04-06
EP1243267A3 (fr) 2002-10-30
EP0978276B1 (fr) 2002-09-11
FI964249A0 (fi) 1996-10-22
JP3622975B2 (ja) 2005-02-23
ATE226074T1 (de) 2002-11-15
ES2180251T3 (es) 2003-02-01
EP0758235A1 (fr) 1997-02-19
EP0978276A3 (fr) 2000-04-12
AU2406895A (en) 1995-11-16
BG100933A (en) 1997-07-31
SK135496A3 (en) 1997-05-07
BR9507502A (pt) 1997-09-02
IL113433A0 (en) 1995-07-31
EP1243267A2 (fr) 2002-09-25
AT5350U1 (de) 2002-06-25
DE69519093D1 (de) 2000-11-16
ES2152485T3 (es) 2001-02-01
AP9500733A0 (en) 1995-04-30
ATE203161T1 (de) 2001-08-15
CZ294168B6 (cs) 2004-10-13
ATE196845T1 (de) 2000-10-15
ES2182754T3 (es) 2003-03-16
NO310703B1 (no) 2001-08-20
DZ1876A1 (fr) 2002-02-17
JPH09512027A (ja) 1997-12-02
EP0758235B1 (fr) 2001-07-18
BG62842B1 (bg) 2000-09-29
RU2152213C1 (ru) 2000-07-10
DE69521799D1 (de) 2001-08-23
WO1995028927A1 (fr) 1995-11-02
CN1149829A (zh) 1997-05-14
DE69521799T2 (de) 2002-06-13

Similar Documents

Publication Publication Date Title
HU9602922D0 (en) Polymer coated tablet comprising amoxycillin and clavulanate
GB2298422B (en) Compounds and their use
ZA966494B (en) New drugs and their use
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
HUP9901092A3 (en) Benzimidazole compounds and their pharmaceutical use
AU7237394A (en) Morphinan derivative and medicinal use
HUP9901437A3 (en) Pharmaceutical formulation, containing amoxycillin and clavulanate
AU4009795A (en) Heterocyclic compounds and their use
AP9701122A0 (en) Composition comprising amoxycillin and clavulanic acid
AU1081897A (en) Heterocyclic compounds and their use
AU3634595A (en) Bis-oxazolidines and their use
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
GB9514816D0 (en) Substances and their medical use
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
HUP9602872A3 (en) Penem derivatives and antimicrobial agent containing the same
AU6366096A (en) Solid polymeric products and their use
AU1292995A (en) Bis-oxazolidine compounds and their use
AU7551896A (en) 1-azabicycloheptane derivatives and their pharmaceutical use
AU7078094A (en) Allatostatins and their use
AU1141497A (en) Heterocyclic compounds and their use
AU5405296A (en) Iso-alpha-acid formulation and its use
AU6470996A (en) 4a-aryldecahydroisoquinoline compounds and medicinal uses thereof
AU5930996A (en) Contrast medium and its use
AU685375B3 (en) Application and storage apparatus
GB9520714D0 (en) Cephem compounds and pharmaceutical use thereoof